LARIMAR THERAPEUTICS INC (LRMR)

US5171251003 - Common Stock

7.765  +0.15 (+2.04%)

After market: 7.765 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
41.76M36.53M50.47M42.80M40.10M
Research and Development
27.67M24.25M38.40M31.41M23.89M
Selling, General, and Administrative Expenses
14.09M12.28M12.07M11.40M16.22M
Operating Income
-41.76M-36.53M-50.47M-42.80M-40.10M
Interest Income/Expense
N/AN/AN/AN/A250.00K
Other Income/Expense
4.81M1.17M-170.00K320.00KN/A
Non Recurring Items
N/AN/AN/AN/A-5.55M
Income Before Taxes
-36.95M-35.36M-50.64M-42.48M-45.41M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-36.95M-35.36M-50.64M-42.48M-45.41M
EBITDA
-41.45M-36.21M-50.14M-42.64M-39.84M
 
Per Share Data
EPS Diluted Total Ops
-0.84-1.37-2.95-3.57-14.59
Non GAAP EPS
-0.85-1.54-2.97-3.94-13.20
 
Statistics

All data in USD

Charts